Clinical trial
Clinical Trial of Lamotrigine to Reverse Cognitive Impairment in Chronic…
NCT00223262 · University of Texas Southwestern Medical Center, Other · Completed
Key facts
| NCT number | NCT00223262 |
|---|---|
| Title | Clinical Trial of Lamotrigine to Reverse Cognitive Impairment in Chronic Corticosteroid-Treated Patients |
| Lead sponsor | University of Texas Southwestern Medical Center, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Memory Impairment Due to Corticosteroid Use, Hypomania Due to Corticosteroid Use, Hippocampal Atrophy Due to Corticosteroid |
| Intervention type | Drug |
| Interventions | Lamotrigine (Drug) |
| Enrollment | 28 |
| Start date | Aug 1, 2002 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Apr 16, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: